Oxybutynin Tablets and Syrup Articles

J&J's Ditropan to get stronger warnings

16 April 2007

Appeals court rules for Mylan on oxybutynin

18 September 2006

Tentative FDA OK for IMPAX generic Ditropan

7 February 2005

Tenetative US appro for Mylan's oxybutynin

24 January 2005

Indevus files for OAB drug trospium in USA

5 May 2003

Watson's incontinence patch cleared by US FDA

3 March 2003

Urinary incontinence market forecasts

10 August 2001

CORRECTION: Uros

9 August 2001

Alza investigates new approaches to treat urge incontinence

18 July 2001

Alza to market Ditropan in Canada

14 June 2001

Ditropan XL vs Detrol study in incontinence

11 April 2001

Johnson & Johnson rumored to be planning takeover bid for Alza Corp

26 March 2001

Alza Corp acquires marketing rights to Flexeril from Merck & Co

6 February 2001

Alza Corp revenues pushing $1 billion

1 February 2001

Despite strong product outlook, flat profits predicted for Yamanouchi to

2 August 2000

Stock Commentary New York

29 June 2000

Sanofi-Synthelabo gains UK approval for Ditropan XL

20 June 2000

Alza and Crescendo get FDA approvable letter for ADHD therapy

25 May 2000

Alza revenues top $200 million mark

20 April 2000

J&J ends Alza JV for E-TRANS - update

23 February 2000

J&J ends Alza JV for E-TRANS

18 February 2000

Latest crop of full-year results show strong sales growth for US pharma

3 February 2000

Busy year for NCEs as major new compound classes launched

6 January 2000

Sanofi-Synthelabo's once-daily Ditropan filed in UK

12 August 1999

Alza Corp to push Ditropan sales

23 July 1999

Abbott Laboratories to acquire Alza Corp in $7.3 billion stock deal

22 June 1999

Alza's Ditropan XL Reduces Urinary Incontinence

17 June 1999

Alza's Ditropan XL vs immediate-release form

28 May 1999

Final crop of US results for first quarter show encouraging signs

13 May 1999

Stock Commentary New York

8 April 1999

Stock Commentary New York

31 March 1999

Alza's Ditropan XL cleared by FDA- updated story

7 January 1999

Alza's Ditropan cleared by FDA

21 December 1998

Analysts Taking Stock Of Pharma Firms, Prospects Still Good

26 November 1998

Alza Boosts Ditropan XL Sales Effort

24 August 1998

Generic Ditropan From Morton

19 March 1997

Sepracor Incontinence Drug Cleared For Trials

9 December 1996

Smith & Nephew Sells Incontinence Medicine To Synthelabo

4 December 1995

Fournier Forces Job Cuts At Debat

9 January 1995

SMITH & NEPHEW GAINS INJUNCTION

21 February 1994

ANANXYL WITHDRAWN FROM MARKET IN FRANCE

1 November 1993

SYNTHELABO EXPECTS 23% RISE IN '93 PROFITS

25 October 1993

ABPI SEES 14 BREACHES OF PRACTICE CODE

12 April 1993

ABPI CODE OF PRACTICE LATEST REPORT

21 December 1992

Showing 1-44 of 44 articles

Go to beginningPrevious
  • 1
NextGo to end